113 tracked 13F filers disclose a position in NPCE as of the latest SEC 13F filings, a combined $351.9M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Polar Capital Holdings Plc | $52.4M | 3.3M | —Held | Q2 2026 | |
| 2 | Soleus Capital Management, L.P. | $46.3M | 2.9M | ▼−0.7% Reduced · −21K sh | Q2 2026 | |
| 3 | MORGAN STANLEY | $33.8M | 2.6M | ▲+0.7% Added · +19K sh | Q1 2026 | |
| 4 | First Light Asset Management, LLC | $32.3M | 2.5M | ▲+82% Added · +1.1M sh | Q1 2026 | |
| 5 | BlackRock, Inc. | $30.9M | 2.3M | ▼−1.6% Reduced · −38K sh | Q1 2026 | |
| 6 | ORBIMED ADVISORS LLC | $27.6M | 2.1M | ▼−13% Reduced · −310K sh | Q1 2026 | |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | $14.8M | 1.1M | →First observed position No prior filed position | Q1 2026 | |
| 8 | DEUTSCHE BANK AG\ | $12.3M | 932K | ▲+0.3% Added · +3K sh | Q1 2026 | |
| 9 | ARMISTICE CAPITAL, LLC | $9.1M | 692K | ▼−13% Reduced · −100K sh | Q1 2026 | |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $10.6M | 666K | ▲+7.8% Added · +48K sh | Q2 2026 | |
| 11 | FMR LLC | $7.3M | 554K | ▼−11% Reduced · −71K sh | Q1 2026 | |
| 12 | STATE STREET CORP | $8.7M | 550K | ▲+11% Added · +53K sh | Q2 2026 | |
| 13 | SILVERCREST ASSET MANAGEMENT GROUP LLC | $4.7M | 360K | ▼−9.2% Reduced · −37K sh | Q1 2026 | |
| 14 | NORTHERN TRUST CORP | $3.2M | 240K | ▲+3.5% Added · +8K sh | Q1 2026 | |
| 15 | Palumbo Wealth Management LLC | $3.3M | 209K | ▼−0.6% Reduced · −1K sh | Q2 2026 | |
| 16 | ESSEX INVESTMENT MANAGEMENT CO LLC | $3.3M | 209K | ▼−4.1% Reduced · −9K sh | Q2 2026 | |
| 17 | VANGUARD PORTFOLIO MANAGEMENT LLC | $2.5M | 187K | →First observed position No prior filed position | Q1 2026 | |
| 18 | Qube Research & Technologies Ltd | $2.4M | 186K | ▼−6.4% Reduced · −13K sh | Q1 2026 | |
| 19 | ALGERT GLOBAL LLC | $2.9M | 185K | ▲+2.9% Added · +5K sh | Q2 2026 | |
| 20 | Russell Investments Group, Ltd. | $2.4M | 179K | ▲+143% Added · +105K sh | Q1 2026 | |
| 21 | VANGUARD FIDUCIARY TRUST CO | $2.3M | 179K | →First observed position No prior filed position | Q1 2026 | |
| 22 | GOLDMAN SACHS GROUP INC | $2.3M | 175K | ▲+6.5% Added · +11K sh | Q1 2026 | |
| 23 | RENAISSANCE TECHNOLOGIES LLC | $2.3M | 174K | ▼−22% Reduced · −48K sh | Q1 2026 | |
| 24 | HighMark Wealth Management LLC | $2.6M | 163K | ▲+159% Added · +100K sh | Q2 2026 | |
| 25 | Point72 Asset Management, L.P. | $2.0M | 152K | ▲+517% Added · +127K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 7 funds opened a new position in NPCE and 19 added to an existing one, while 24 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| MICROSOFT CORPMSFT | 54 funds | $116.4B |
| MICRON TECHNOLOGY INCMU | 54 funds | $20.1B |
| AMAZON.COM INCAMZN | 53 funds | $81.6B |
| ALPHABET INC-CL AGOOGL | 53 funds | $68.2B |
| ELI LILLY & COLLY | 53 funds | $34.2B |
| JPMORGAN CHASE & COJPM | 53 funds | $27.5B |
| VISA INC-CLASS A SHARESV | 53 funds | $27.1B |
| ADVANCED MICRO DEVICESAMD | 53 funds | $19.7B |
| BANK OF AMERICA CORPBAC | 53 funds | $14.4B |
| MORGAN STANLEYMS | 53 funds | $10.6B |
| NVIDIA CORPNVDA | 52 funds | $178.0B |
| META PLATFORMS INC-CLASS AMETA | 52 funds | $48.1B |
Ranked by how many of NPCE's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Dec 15, 2025 | Morrell Martha | CHIEF MEDICAL OFFICER | Sell (S) | 25K | $399K |
| May 14, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell (S) | 34K | $542K |
| May 14, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell (S) | 134K | $2.1M |
| Feb 21, 2025 | Morrell Martha | CHIEF MEDICAL OFFICER | Sell (S) | 78K | $1.1M |
| Feb 20, 2025 | KCK LTD. | 10% Owner | Sell (S) | 5.3M | $49.5M |
| Jan 30, 2025 | Morrell Martha | CHIEF MEDICAL OFFICER | Sell (S) | 200 | $3K |
| Jan 29, 2025 | Morrell Martha | CHIEF MEDICAL OFFICER | Sell (S) | 100 | $2K |
| Jan 24, 2025 | Morrell Martha | CHIEF MEDICAL OFFICER | Sell (S) | 3K | $48K |
| Oct 25, 2024 | KCK LTD. | 10% Owner | Sell (S) | 224K | $1.2M |
| Oct 23, 2024 | KCK LTD. | 10% Owner | Sell (S) | 147 | $885 |
| Oct 22, 2024 | KCK LTD. | 10% Owner | Sell (S) | 4K | $25K |
| Oct 21, 2024 | KCK LTD. | 10% Owner | Sell (S) | 4K | $23K |
Connected entities for NPCE
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/NPCE/capital-change-brief"
Use Arkolith's capital_change_brief for NPCE. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for NPCE. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.